Magmil100 ml

Magmil is indicated for:

• Antacid use (established, FDA-approved OTC indication): relief of occasional heartburn, acid indigestion, and upset stomach associated with these symptoms, typically used at lower doses.
• Laxative use (established, FDA-approved OTC indication): relief of occasional constipation, typically used at higher doses (commonly known as "Milk of Magnesia").

Magmil is intended for short-term, occasional use for either indication rather than long-term daily therapy.

Each formulation of Magnesium Hydroxide contains magnesium hydroxide as the active ingredient, available as an oral suspension (commonly 400 mg/5 mL), chewable tablets (commonly around 311-622 mg), or caplets. Strength varies by brand and dosage form; refer to the product label for the exact concentration.

Magmil is an inorganic compound that functions as both an antacid and a saline (osmotic) laxative. As an antacid, it neutralizes stomach acid directly. As a laxative, poorly absorbed magnesium ions draw water into the intestinal lumen by osmosis, softening stool and stimulating bowel movement.

Magmil is available over-the-counter in oral suspension, chewable tablet, and caplet forms and is widely used both in Bangladesh and internationally.

Magmil belongs to the therapeutic classes of antacids and saline (osmotic) laxatives.

Mechanism (antacid): Magnesium Hydroxide reacts chemically with hydrochloric acid in the stomach to form magnesium chloride and water, neutralizing gastric acid and raising gastric pH, which relieves symptoms of heartburn and acid indigestion.

Mechanism (laxative): Magnesium ions are poorly absorbed from the gastrointestinal tract. The osmotic effect of unabsorbed magnesium ions draws water into the small and large intestine, increasing intraluminal volume, softening stool, and promoting peristalsis and bowel evacuation, usually within 30 minutes to 6 hours.

A small fraction of ingested magnesium (roughly 15-30%) is absorbed systemically and is excreted renally in patients with normal kidney function; impaired renal clearance can lead to magnesium accumulation.

Magmil oral suspension should be shaken well before each use. It may be taken with a small amount of water or fruit juice to improve palatability if needed, and may be taken with or without food. Chewable tablets should be chewed thoroughly before swallowing and can be followed with a glass of water or milk. When used as an antacid, doses may be taken after meals and at bedtime as needed for symptom relief.

Magmil raises gastric pH and provides poorly-absorbed magnesium ions, which can significantly reduce the absorption and effectiveness of several medicines if taken together. Clinically significant interactions include:

• Tetracycline and fluoroquinolone antibiotics (e.g., doxycycline, ciprofloxacin): magnesium chelates with these antibiotics, markedly reducing their absorption and efficacy. Separate administration by at least 2-4 hours.
• Oral iron supplements: reduced iron absorption; separate dosing by 2 hours or more.
• Bisphosphonates (e.g., alendronate): reduced absorption; separate dosing by at least 2 hours, per bisphosphonate labeling.
• Digoxin: may reduce digoxin absorption/serum levels; monitor if co-administered.
• Enteric-coated or delayed-release medications: the rise in gastric pH from Magmil may cause premature dissolution of enteric coatings, leading to early drug release and possible stomach irritation or reduced efficacy.

As a general precaution, other oral medications should be taken at least 2 hours before or after Magmil unless a physician or pharmacist advises otherwise.

Common side effects of Magmil, especially at laxative doses, include:

• Diarrhea (common, dose-related)
• Abdominal cramping or discomfort
• Nausea

Hypermagnesemia: Excessive or prolonged use of Magmil, or use in patients with impaired renal function, can lead to elevated blood magnesium levels. Symptoms range from mild (nausea, lethargy, facial flushing) to severe (muscle weakness, hypotension, cardiac arrhythmia, respiratory depression), particularly in patients with renal impairment. This is a genuine, well-established safety concern requiring caution — see Contraindications and Precautions.

Magmil is generally considered acceptable for occasional use during pregnancy for both antacid and laxative indications, as systemic absorption of magnesium is minimal in patients with normal renal function. However, Magmil should be used only if clearly needed, and regular or prolonged use during pregnancy should only occur under medical supervision, as excessive magnesium intake close to delivery has rarely been associated with neonatal effects. Magmil is generally considered compatible with breastfeeding at recommended doses, as minimal magnesium is transferred into breast milk relative to normal dietary intake. Pregnant or breastfeeding women should consult a physician before regular or prolonged use.

Use Magmil with caution in the following situations:

• Renal impairment: Patients with kidney disease are at increased risk of hypermagnesemia and should avoid regular or prolonged use of Magmil unless directed by a physician (see Contraindications and Side Effects).
• Duration of use: Do not use as a laxative for more than 1 week, or as an antacid for more than 2 weeks, without consulting a physician, as prolonged use may mask symptoms of a more serious underlying condition.
• Sodium-restricted or magnesium-restricted diets: Consult a physician before use if on a special diet.
• Rectal bleeding or failure to have a bowel movement after use: may indicate a serious condition; discontinue and consult a physician.
• Drug spacing: Take other oral medications at least 2 hours apart from Magmil to avoid reduced absorption (see Interactions).

Overdose or excessive use of Magmil may cause severe diarrhea, dehydration, electrolyte imbalance, and hypermagnesemia, which can present as muscle weakness, low blood pressure, slowed heart rate, confusion, or in severe cases, respiratory depression and cardiac arrhythmia, particularly in patients with renal impairment. If overdose is suspected, seek immediate medical attention or contact a poison control center right away. Do not attempt specific home treatment; supportive care and medical evaluation are required.

Store at room temperature (below 30°C), away from light and moisture. Shake the oral suspension well before use and do not allow it to freeze. Keep out of reach of children.

Pediatric use: Magmil as a laxative may be used in children 2 years and older at age-appropriate doses (see Dosage and Administration); use in children under 2 years should only be under a physician's direction. Use as an antacid in children under 12 years should be guided by a physician, as safety and efficacy for self-directed antacid use in young children have not been well established.

Elderly: Older adults, who more commonly have age-related decline in renal function, are at higher risk of hypermagnesemia and should use Magmil cautiously, generally avoiding regular or prolonged use without medical supervision.

Renal impairment: See Contraindications and Precautions — regular use is not recommended in significant renal impairment.

Hepatic impairment: No well-established dose adjustment is required, as Magmil is not significantly hepatically metabolized.

Magmil is intended for short-term, occasional use. As a laxative, it should not be used for more than 1 week continuously. As an antacid, it should not be used for more than 2 weeks continuously. If symptoms persist beyond these periods or recur frequently, a physician should be consulted to evaluate for an underlying condition.

Antacid; Saline (Osmotic) Laxative

Magnesium Hydroxide acts as a base that neutralizes gastric hydrochloric acid (antacid effect) and, when insufficiently absorbed in the gut, exerts an osmotic effect that draws water into the intestinal lumen to soften stool and stimulate bowel movement (laxative effect). Both actions arise from the same poorly-absorbed magnesium hydroxide molecule acting at different sites and doses.

Magmil may be used as a laxative in children 2 years of age and older at weight/age-appropriate doses under adult supervision (see Dosage and Administration table). Use in children younger than 2 years should occur only on the advice of a physician. For antacid use in children under 12 years, safety and efficacy of self-directed use have not been well established, and a physician should be consulted before use.